Forecast: Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods in Austria

From 2013 to 2023, healthcare expenditure on pharmaceuticals and medical non-durable goods in Austria exhibited both fluctuations and gradual growth. After a decline in 2013, the expenditure saw slight increases and decreases, stabilizing between 2014 and 2019. A significant rise occurred in 2020, followed by a steady expenditure in 2021 and 2022, with a minor increase by 0.72% in 2023. This indicates a gradual recovery with a CAGR of 2.31% over the last five years. Expenditure in 2023 stood at 1.39 units of GDP. Forecasts for 2024-2028 suggest a modest growth rate of 1.44% over this period, with a five-year CAGR of 0.29%.

Future trends to watch for:

• Potential impacts of policy changes on pharmaceutical expenditure.
• Introduction of new, expensive treatments and technologies.
• Aging population dynamics that could increase demand.
• Global economic fluctuations affecting healthcare budgets.